|
Re: Presentation is over
|
2
|
Resverlogix Corp.
|
Jun 09, 2020 08:17AM
|
|
Re: Presentation is over
|
2
|
Resverlogix Corp.
|
Jun 09, 2020 08:01AM
|
|
Presentation is over
|
1
|
Resverlogix Corp.
|
Jun 09, 2020 06:48AM
|
|
Re: Led Gac
|
5
|
Resverlogix Corp.
|
Jun 08, 2020 09:48PM
|
|
Re: 57th ERA-EDTA Congress Abstracts
|
1
|
Resverlogix Corp.
|
Jun 08, 2020 05:41PM
|
|
Re: Led Gac
|
2
|
Resverlogix Corp.
|
Jun 08, 2020 05:28PM
|
|
Re: Led Gac
|
6
|
Resverlogix Corp.
|
Jun 08, 2020 04:56PM
|
|
Re: Resverlogix Announces Corporate Update Conference Call ... Bear
|
5
|
Resverlogix Corp.
|
Jun 07, 2020 05:45PM
|
|
Re: Resverlogix Announces Corporate Update Conference Call ... Bear
|
3
|
Resverlogix Corp.
|
Jun 07, 2020 12:37PM
|
|
Re: PAH article
|
2
|
Resverlogix Corp.
|
Jun 07, 2020 07:39AM
|
|
Re: Resverlogix Announces Corporate Update Conference Call & Webcast on June 10, 2020 and Upcoming Presentation at the 57th ERA-EDTA Virtual Congress on
|
5
|
Resverlogix Corp.
|
Jun 07, 2020 07:28AM
|
|
Re: Lower LDL-C and Increased Type 2 Diabetes Risk - Bear
|
3
|
Resverlogix Corp.
|
Jun 06, 2020 01:38PM
|
|
Re: Bear
|
7
|
Resverlogix Corp.
|
Jun 06, 2020 01:12PM
|
|
Re: Bear
|
1
|
Resverlogix Corp.
|
Jun 06, 2020 09:18AM
|
|
Re: Resverlogix Announces Corporate Update Conference Call...
|
7
|
Resverlogix Corp.
|
Jun 06, 2020 09:15AM
|
|
Re: Bear
|
7
|
Resverlogix Corp.
|
Jun 06, 2020 08:59AM
|
|
Re: Apabetalone, a drug that reduces MACE in CKD patients
|
3
|
Resverlogix Corp.
|
Jun 05, 2020 07:41PM
|
|
Re: AND, APABETALONE REDUCES CONGESTIVE HEART FAILURE INCIDENCE
|
3
|
Resverlogix Corp.
|
Jun 05, 2020 07:37PM
|
|
Re: Resverlogix Announces Corporate Update Conference Call & Webcast on June 10, 2020 and Upcoming Presentation at the 57th ERA-EDTA Virtual Congress on
|
5
|
Resverlogix Corp.
|
Jun 05, 2020 07:27PM
|
|
Resverlogix Announces Corporate Update Conference Call & Webcast and Upcoming Presentation at the 57th ERA-EDTA Virtual Congress
|
2
|
Resverlogix Corp.
|
Jun 05, 2020 07:20PM
|
